Management of Tooth Extraction in Patients Taking Antiresorptive Drugs: An Evidence Mapping Review and Meta-Analysis

Management of Tooth Extraction in Patients Taking Antiresorptive Drugs: An Evidence Mapping Review and Meta-Analysis

Background: Medication-related osteonecrosis of the jaw (MRONJ) is a well-known severe adverse reaction of antiresorptive, antiangiogenic or targeted therapies, and usually occurs after tooth extraction. This review is aimed at determining the efficacy of any intervention of tooth extraction to redu...

Full description

Bibliographic Details
Main Authors:	Chang Liu, Yu-Tao Xiong, Tao Zhu, Wei Liu, Wei Tang, Wei Zeng
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Journal of Clinical Medicine
Subjects:	medication-related osteonecrosis of the jaw tooth extraction preventive dentistry evidence mapping meta-analysis
Online Access:	https://www.mdpi.com/2077-0383/12/1/239

Similar Items

Evaluation of Preventive Role of Systemically Applied Erythropoietin after Tooth Extraction in a Bisphosphonate-Induced MRONJ Model
by: Gonca Duygu, et al.
Published: (2023-05-01)

The biological mechanisms of the antiresorptive therapy of osteoporosis, and the antiresorptive drug related osteonecrosis of jaws
by: István Gera, et al.
Published: (2024-03-01)

Medication-related osteonecrosis of the jaw after tooth extraction in patients receiving pharmaceutical treatment for osteoporosis: A retrospective cohort study
by: Keisuke Seki, et al.
Published: (2022-10-01)

What Do Prescribers of Bone Modifying Agents Know about Medication-Related Osteonecrosis of the Jaw? Is Current Prevention Enough?
by: Mihai Vlad Golu, et al.
Published: (2022-09-01)

<i>ONJ (MRONJ) Update 2021</i>—Osteonecrosis of Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment: A 2021 Web Event
by: Vittorio Fusco, et al.
Published: (2022-04-01)

Medication‐related osteonecrosis of the jaw and successful implant treatment in a patient on high‐dose antiresorptive medication: A case report
by: Camilla Ottesen, et al.
Published: (2022-10-01)

Medication-Related Osteonecrosis of the Jaw: A Critical Narrative Review
by: Alejandro I. Lorenzo-Pouso, et al.
Published: (2021-09-01)

Effect of Antiresorptive Drugs on Osseointegrated Dental Implants: A Systematic Review
by: Joyce Tin Wing Li, et al.
Published: (2024-04-01)

Rat Calvaria Model Mimicking the Intraoral Lesion of Medication-Related Osteonecrosis in the Jaw: A Preliminary Test
by: Yesel Kim, et al.
Published: (2023-10-01)

Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review
by: Aloizio Premoli Maciel, et al.
Published: (2020-07-01)

Incidence and Risk of Anti-Resorptive Agent-Related Osteonecrosis of the Jaw after Tooth Extraction: A Retrospective Study
by: Rieko Shimizu, et al.
Published: (2022-07-01)

Incidence of antiresorptive agent-related osteonecrosis of the jaw: A multicenter retrospective epidemiological study in Hyogo Prefecture, Japan
by: Masanori Nashi, et al.
Published: (2023-07-01)

Comparison of Different Antibiotic Regimes for Preventive Tooth Extractions in Patients with Antiresorptive Intake—A Retrospective Cohort Study
by: Oliver Ristow, et al.
Published: (2023-06-01)

Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws
by: Emily Sunny Lee, et al.
Published: (2023-11-01)

Genome-wide association study of osteonecrosis of the jaw in Danish patients receiving antiresorptive therapy for osteoporosis: A case-control study
by: Alma B. Pedersen, et al.
Published: (2023-06-01)

Use and risk of side effects of antiresorptive medication in people with intellectual disabilities [version 1; peer review: 2 approved]
by: Valeria Frighi, et al.
Published: (2022-12-01)

Bisphosphonate-Related Osteonecrosis of the Jaws. A Severe Side Effect of Bisphosphonate Therapy
by: Zuzana Janovská
Published: (2012-01-01)

Long-term treatment with alendronate increases the surgical difficulty during simple exodontias – an in vivo observation in Holtzman rats
by: Conte-Neto Nicolau, et al.
Published: (2012-07-01)

Incidence and risk factors for medication‐related osteonecrosis after tooth extraction in cancer patients—A systematic review
by: Nurda Schwech, et al.
Published: (2023-02-01)

18 Years of Medication-Related Osteonecrosis of the Jaw (MRONJ) Research: Where Are We Now?—An Umbrella Review
by: Roberto Sacco, et al.
Published: (2021-09-01)

Surgical management in patients with bisphosphonate-related osteonecrosis of the jaw: four cases
by: Emre Dikicier, et al.
Published: (2014-12-01)

Histomorphometric assessment of bone necrosis produced by two cryosurgery protocols using liquid nitrogen: an experimental study on rat femurs
by: Fábio Wildson Gurgel Costa, et al.
Published: (2011-12-01)

Could Local Application of Hypoxia Inducible Factor 1-α Enhancer Deferoxamine Be Promising for Preventing of Medication-Related Osteonecrosis of the Jaw?
by: Gül Merve Yalcin-Ülker, et al.
Published: (2023-03-01)

Medication-Related Osteonecrosis: Why the Jawbone?
by: Sydney Kuehn, et al.
Published: (2023-04-01)

Design and methods for a Scandinavian pharmacovigilance study of osteonecrosis of the jaw and serious infections among cancer patients treated with antiresorptive agents for the prevention of skeletal-related events
by: Acquavella J, et al.
Published: (2016-07-01)

The Role of the Laser Photobiomodulation (PBM) in the Management of Patients at Risk or Affected by MRONJ
by: Alessandro Del Vecchio, et al.
Published: (2022-01-01)

Prevention and treatment of oral adverse effects of antiresorptive medications for osteoporosis – A position paper of the Brazilian Society of Endocrinology and Metabolism (SBEM), Brazilian Society of Stomatology and Oral Pathology (Sobep), and Brazilian Association for Bone Evaluation and Osteometabolism (Abrasso)
by: Miguel Madeira, et al.
Published: (2020-10-01)

Epi-Mucosa Fixation and Autologous Platelet-Rich Fibrin Treatment in Medication-Related Osteonecrosis of the Jaw
by: Antonio Cortese, et al.
Published: (2021-04-01)

Synthetic Hydroxyapatite Inhibits Bisphosphonate Toxicity to the Oral Mucosa In Vitro
by: George Bullock, et al.
Published: (2020-05-01)

BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY
by: George Adrian Ciobanu, et al.
Published: (2022-08-01)

Bisphosphonates: An update to the general dentist
by: Varun Dahiya, et al.
Published: (2013-01-01)

Real-world study of antiresorptive-related osteonecrosis of jaw based on the US food and drug administration adverse event reporting system database
by: Jing Peng, et al.
Published: (2022-10-01)

Medication‐related osteonecrosis of the jaw leading to sepsis in a patient with rheumatoid arthritis: A case report and clinical implications
by: Kazuhiko Iwasaki, et al.
Published: (2023-06-01)

Çene kemiklerinin yeni tehlikesi: bisfosfonatlar
by: Huseyin Koca, et al.
Published: (2011-11-01)

Is using Bisphosphonate a Contraindication for Dental Treatments?
by: Mohadese Heidari, et al.
Published: (2017-11-01)

Development of Osteonecrosis of the Jaw in a Patient Receiving Oral Bisphosphonates for Osteoporosis: A Case Report
by: Sina Esmaeilzadeh, et al.
Published: (2014-08-01)

Identification of Potentially Pathogenic Variants Associated with Recurrence in Medication-Related Osteonecrosis of the Jaw (MRONJ) Patients Using Whole-Exome Sequencing
by: Songmi Kim, et al.
Published: (2022-04-01)

Clinical experiences with bisphopsphonate induced osteochemonecrosis of the jaws
by: C Dannemann, et al.
Published: (2006-08-01)

Using robot technology to analyze forces and torques in tooth removal
by: Tom C.T. van Riet, et al.
Published: (2023-03-01)

Laser Devices and Autologous Platelet Concentrates in Prevention and Treatment of Medication-Related Osteonecrosis of the Jaws: A Systematic Review
by: Andrea Scribante, et al.
Published: (2023-05-01)